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Abstract
BACKGROUND: Non-specific cardiac symptoms in female patients with rheumatoid arthritis (RA) could indicate early cardio-
vascular disease. 
MATERIALS AND METHODS: Myocardial perfusion imaging (MPI), with 99mTc tetrofosmin stress–rest single photon emission 
computer tomography (SPECT), in 13 RA female patients with atypical cardiac symptoms, was compared to 44 weight- and 
age-matched females with similar cardiac complaints (control group). Smoking, hypertension, diabetes mellitus, dyslipidemia, 
obesity and cardiac heredity were recorded and compared between the study and control group. MPI was assessed using 17 
segment polar map and with a scale of 0 to 5 scoring. 
RESULTS: Patients with RA demonstrated higher cardiovascular risk (46%) compared to control individuals (17%). In addition, 
patients with RA had more irreversible myocardial ischemic abnormalities in their MPI than the control group. Dyslipidemia and 
obesity was found more frequent in RA patients with MPI SSS ≥ 4.
CONCLUSION: RA patients with atypical cardiac complaints are at higher risk for cardiovascular disease; early detection and 
monitoring of this patient group could potentially reverse or successfully manage the consequences of the upcoming cardio-
vascular disease.
KEY words: myocardial perfusion imaging, myocardial ischemia, tetrofosmin, risk factors, females, rheumatoid 
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Introduction
Rheumatoid arthritis (RA) is an inflammatory disease involving 
multiple systems that predominantly cause joint destruction but 
also affect extra-articular organs resulting in significant functional 
disabilities and reduced quality of life [1–4]. Patients with either RA 
or other chronic inflammatory rheumatoid diseases may develop 
progressive cardiovascular disease [5]. These cardiovascular 
complications consist of increased rate of coronary artery disease 
and systemic atherosclerosis [6].
Several cardiovascular imaging modalities exist, such as nu-
clear imaging, cardiac computed tomography and carotid ultra-
sonography, to evaluate patients with increased cardiovascular risk 
[7]. Myocardial perfusion imaging (MPI), employing single photon 
emission tomography (SPECT), is a highly reliable imaging method 
to assess myocardial ischemia. Its sensitivity has been reported 
to reach 85%, specificity of 83%, positive predictive value of 66%, 
negative predictive value of 94% and accuracy of 84% [8]. Myocar-
dial perfusion imaging with pharmacologic stress may represent 
the imaging test of choice in female patients with reduced exercise 
capability such as the RA patients, reaching sensitivity of 80–85% 
and specificity of 84–93% [9].
Several risk factors have been linked to coronary-artery disease 
in RA patients. Metabolic syndrome seems to exist in a higher rate 
in patients with RA, consisted of 31% in patients with early RA and 
42% in patients with long-standing RA, compared to only 11% in 
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matched control individuals [10]. Thus, early detection of metabolic 
syndrome and control of risk factors such as smoking, dyslipidemia, 
hypertension, and obesity is warranted in RA patients [6]. Traditional 
risk factors for cardiovascular disease seem to confer the same 
risk for either RA or non-RA patients [11, 12].
In this retrospective study, we evaluated the rate of myo-
cardial ischemia and the role of cardiac risk factors, after using 
–99mTc-TF-SPECT MPI in female patients with rheumatoid arthri-
tis and compared them to an age and weight matched control 
group.
Patients and methods
Study Participants
An extensive request in the medical records of the Nuclear 
Medicine Department of our University Hospital between 2011 
and 2016 has been achieved summing up patients with RA 
who were subjected to myocardial perfusion imaging with 99m 
Tc tetrofosmin in stress–rest single photon emission computer 
tomography (MPI – 99mTc-TF-SPECT). For retrieving specific 
data, inclusion criteria were applied such as no other disease 
existed than RA, atypical cardiac complaints such as chest wall 
pain, palpitations, without known cardiac disease, and negative 
electrocardiograph (ECG). We found 16 patients with RA who 
underwent the test, 13 females and 3 males. All patients followed 
one day protocol. The stress protocol was either pharmacologi-
cal or Bruce treadmill exercise test. Patients when subjected to 
99mTc-TF-SPECT MPI were routinely recorded with ECG at the 
beginning and continuously monitored during stress time. Any 
changes in ECG were noted in the medical charts. The imaging 
protocol used for 99mTc-TF-SPECT MPI has been described in 
our previous studies [13, 14] and performed according to pub-
lished guidelines [15]. According to our search, only three male 
patients were found and finally excluded from the study due to their 
minimal contribution to the whole dataset, and thus, only the 13 
females were evaluated. For the selection of the healthy individuals, 
120 female patients that underwent the same test without posi-
tive RA diagnosis were initially selected to form the control group. 
These females had the test for atypical cardiac complaints such 
as nonspecific chest pain or palpitations with no medical disease, 
negative history for cardiac disease, negative clinical evaluation 
and negative ECG prior to MPI. Among these females, 44 were 
age- and weight-matched with the RA patients and finally selected 
to form the control group. In both groups, major cardiovascular 
risk factors were recorded, including smoking when either active 
or ceased within the last 3 months prior to the test, hypertension 
and/or diabetes mellitus and/or dyslipidemia, obesity and family 
history of cardiovascular disease.
This retrospective study was performed after approval by the 
Hospital’s Clinical Research Committee. As a retrospective analy-
sis of MPI data, prior written patients consent was not obtained since 
it was not required by our Hospital’s Clinical Research Committee. 
All subjects were blinded during statistical analysis.
MPI evaluation
For MPI evaluation, two nuclear medicine physicians indepen-
dently evaluated the images, and a third nuclear medicine physi-
cian participated when a difference in MPI scoring among the two 
nuclear medicine physicians existed. Scoring was evaluated with 
a 17-segment polar map, [16] with a scale of 0 to 5, according to 
the severity of the myocardial perfusion deficit. Thus, when there 
was normal isotope uptake by the total area of myocardium. the 
score was 0. When there was a mild decreased activity, the score 
recorded as 1. Mild to moderate decreased activity had a score of 
2. Moderately decreased myocardial activity was rated as 3. Score 
4 denoted a severely compromised myocardial isotope uptake, 
and score 5 characterized the lack of myocardial tracer activity. All 
segments were scored according to the grade of the defect seen 
and these individual scores were then summed to offer a measure-
ment of abnormality of the entire myocardium. Thus, stress and 
rest MPI was evaluated as the summed stress score (SSS) and the 
summed rest scores (SRS) of the 17-segment polar map. Myocar-
dial perfusion imaging scan was evaluated as abnormal when SSS 
was ≥ 4, with mild ischemia when SSS was graded from 4 to 8, 
moderate from 9 to 13, and severe when summed score was > 13. 
[17] The difference between the summed stress and summed rest 
scores (SSS-SRS) were reflective of the burden and non-reversible 
nature of the existing ischemia [18].
Table 1. Characteristics of the patients (median, min-max), information concerning cardiac risk factors and myocardial perfusion imaging
Characteristics Patients (#13) Control group (#44) P
Age (median, ± SD) 67.8 ± 8.34 67.5 ± 7.53 NS
Weight 71.85 (53–90) 70.98 (54–93) NS
Smoking 3 (23.1%) 4 (9.1%) 0.038
Hypertension 10 (76.9%) 34 (77.3%) NS
Diabetes Mellitus 2 (15.4%) 10 (22.7%) NS
Dyslipidemia 9 (69.2%) 29 (65.9%) NS
Obesity 3 (23.1%) 11 (25.0%) NS
Cardiac Heredity 5 (38.5%) 16 (36.4%) NS
MPI  SSS < 4 7 (53.8%) 37 (84.1%) 0.022*
MPI  SSS ≥ 4 6 (46.2%) 7 (15.9%) 0.004*
MPI: myocardial perfusion imaging; b. SSS: summed stress score; c. NS: non-significant; d. SD: standard deviation; e. * p ≤ 0.05 was considered to be statistically 
significant
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Statistical Analysis
For statistical analysis and MPI evaluation, we used SPSS 
version 20 for windows (SPSS, Chicago, IL), and Microsoft Excel 
version 2013 (© Microsoft). Rheumatoid arthritis patients and 
control group were separately analyzed after splitting into two 
subgroups (one with SSS < 4 and another with SSS ≥ 4). Risk 
factors were evaluated in each group and each subgroup. Baseline 
characteristics were described using median and frequencies for 
categorical variables (using a χ2 test for comparisons of discrete 
variables). P < 0.05 was considered significant. Furthermore, due 
to the small number of RA patients, we evaluated the summed 
segments (basal, mid and apical segments) of anterior, anter-
oseptal, inferoseptal, inferior, inferolateral, anterolateral and apical 
cardiac wall.
Results
The characteristics and MPI of the 13 RA patients and 44 control 
females are shown in Table 1. Comparison of patients with RA and 
control females demonstrated a statistically significantly higher 
number of patients in the RA group with a MPI value of SSS ≥ 4, 
(6/13, 46%) compared to control females 7/44 (16%) (P = 0.004), 
(Tab. 1). Among the RA patients, one had mild ischemia (1/6, 
16%), four had moderate ischemia (4/6, 68%) and one had severe 
ischemia (1/6, 16%). All patients with abnormal MPI test in the 
control group had only mild ischemia. 
Among all patients with RA, a total of 221 segments (17 x 13) 
were evaluated in MPI SSS and 221 segments in SRS. Of them, 
23 segments in SSS and 18 segments in SRS had at least 
a mildly decreased activity scored with 1. Total score in those seg-
ments were 69 in SSS and 34 in SRS. The difference SSS-SRS 
was 5 segments with total score of 35. Control females had 
748 segments (17  x 44) evaluated with 46 segments exhibiting 
decreased activity in SSS and 15 in SRS. Total score in those 
segments were74 in SSS and 26 in SRS. The difference SSS-SRS 
was 31 segments with total score of 48. Assessment of MPI in 
all 102 segments of the 6 RA patients with SSS ≥ 4 revealed 
16 segments that exhibited score1 in SSS and 14 segments with 
score 1 in SRS. Total score was 57 and 29 respectively. The dif-
ference SSS-SRS was 2 segments with total score of 28. Among 
the 119 segments of the 7 control females with SSS ≥ 4, 14 seg-
ments scored 1 in SSS and 5 segments similarly scored 1 in SRS. 
Total score was 35 in SSS and 8 in SRS. The difference SSS-SRS 
was 9 segments with total score of 27 (Table 2). 
Thus, among the RA patients, there were 5/23 (22%) myocar-
dial segments having 51% reversible abnormalities assessed by 
the SSS-SRS MPI. In the contrary, the control females had milder 
abnormalities consisting of 31/46 segments with 67% reversible 
abnormalities in their SSS-SRS MPI. Among those RA patients with 
a SSS ≥ 4, only 2/16 (13%) segments demonstrated changes in 
SSS-SRS MPI consisting with 49% reversibility. In the contrary, 
control females had 9/14 (64%) myocardial segments with 77% 
reversible lesions. These results suggest that patients with RA had 
more irreversible myocardial ischemic abnormalities in their MPI 
than the control group. 
An additional analysis has been performed based on the 
different cardiac segments. As shown in Table 3, although the 
anterolateral segment may be the most affected part of the 
myocardium in patients with RA, the results could be noted with 
skepticism due to the small number of RA patients. In the rest 
of myocardium, the number of segments with ischemia showed 
only a minor increase in the RA compared with the control group. 
However, this minor increase could be due to statistically insignifi-
cant variations secondary to small size of patients’ dataset. The 
cardiovascular risk factors in RA and control patients are shown in 
Table 4. It appears that more RA patients with SSS ≥ 4 compared to 
those with SSS < 4 had hypertension, dyslipidemia and obesity. In 
addition, more RA patients than control females with SSS ≥ 4 had 
dyslipidemia and obesity.
Limitations of the study
The limitations of the study included its retrospective nature 
and the small number of RA patients. In addition, limited data 
was available concerning disease activity and the anti-inflammatory 
Table 2. Number of segments and total score evaluated in MPI 
(summed stress score, summed rest score and their difference) in RA 
patients and control females 
Individuals Segments/MPI Summed 
scores
Total 748/44
Control all SSS 46/44 74 
SRS 15/44 26 
Difference SSS-RSS 31/44 48
Total 221/13
RA all SSS 23/13 69 
SRS 18/13 34 
Difference SSS-RSS 5/13 35
Total 119/7
Control SSS ≥ 4 SSS 14/7 35 
 SRS  5/7 8
Difference SSS-RSS 9/7 27 
Total 102/6
RA SSS ≥ 4 SSS 16/6 57 
SRS 14/6 9 
Difference SSS-RSS   2/6 28 
a. RA: patients with rheumatoid arthritis; b. MPI: myocardial perfusion imaging; c. SSS: 
Summed stress score; d. SRS: Summed rest score
Table 3: Evaluation of the segments in MPI in patients and controls 
with SSS ≥ 4
Segments SSS ≥ 4/Segments SRS
MPI RA Controls 
anterior  8/4 8/2
anteroseptal 2/1 0/0 
inferoseptal 8/3 3/1 
inferior 11/8 4/1
inferolateral 0/0 3/0
anterolateral 20/8 10/5 
Apex 8/5 0/0 
a. MPI: myocardial perfusion imaging; b. SSS: summed stress score; c. SRS: summed rest 
score; d. RA: patients with rheumatoid arthritis
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drugs used for management. Furthermore, no body mass index 
could be calculated since only weight but not height was recorded 
in the medical charts of the patients. 
Discussion
In the present study, higher cardiovascular risk was found 
in RA patients with nonspecific cardiac symptoms compared to 
controls with similar symptoms. Specifically, in our study, 58% 
of RA patients had myocardial abnormalities in MPI, indicating 
ischemia. In accordance with our results, another study in 18 
RA patients without a known cardiac disease reported a rate of 
myocardial abnormalities of 45% [19]. However, in that study, only 
78% were females, and the imaging method performed was MRI. 
Asymptomatic RA patients may display myocardial ischemia at 
similar levels to DM patients [20]. In a study of 106 females with 
RA the incidence of coronary heart disease has been reported 
as 7  per 1000 patients-years [20]. Right and left ventricular di-
astolic dysfunction is diagnosed more frequently in patients with 
early stage RA, with left ventricular diastolic dysfunction linked to 
coronary heart disease [22]. 
This high rate of cardiac abnormalities in RA patients even 
without any clinical symptoms or ECG changes may be due to 
microvasculitic abnormalities [23]. When a systemic inflammation 
is present in RA patients, the cardiac disease may be manifested 
with more clinical findings and atherosclerosis might lead to in-
creased cardiovascular morbidity [24]. Thus, apart from traditional 
risk factors, atherosclerosis in RA patients may be aggravated 
by disease activity, such as polymorphonuclear cell counts, ra-
diographic evidence of cumulative inflammation, serum uric acid 
increased levels, hypothyroidism [25], and increased erythrocyte 
sedimentation rate [26]. However, another study reported no cor-
relation of coronary artery disease in RA patients with the titers of 
rheumatoid factor, body mass index and hypercholesterolemia [27]. 
In our study due to lack of detailed information about the disease 
activity of RA patients and mode of treatment we were not able to 
assess these parameters in relation to cardiovascular risk.
Overall in our study, the traditional cardiovascular risk fac-
tors were not significantly different between patients and control 
females even though RA that exhibited an abnormal MPI had 
a higher rate of dyslipidemia and obesity compared to control 
individuals. However, diabetes mellitus and cardiac heredity were 
attributes seen at higher rates in controls than in RA patients in 
our study. In accordance with our study, previously published 
results indicate that the traditional cardiovascular risk factors in 
RA patients cannot entirely explain their increased incidence of 
coronary heart disease [28]. Although the traditional cardiovascular 
risk factors were similar in a group of 68 RA patients compared to 
64 controls, RA patients had the propensity to develop coronary 
artery disease twice as frequently as the control individuals [11]. 
In addition, another study indicated that RA patients develop car-
diovascular disease almost ten years earlier than their age- and 
sex-matched individuals and tend to suffer twice as frequently 
myocardial infarction compared to their counterparts [29]. Apart 
from myocardial infarction, heart failure due to left ventricular dias-
tolic dysfunction is linked to increased cardiovascular mortality in 
patients with RA. Thus, diagnosis of heart failure in early asympto-
matic stages is more likely to be treatable in RA patients [30, 31]. 
A study in 144 RA women, exhibiting low risk of cardiovascular 
disease as assessed by the Systematic COronary Risk Evaluation 
(SCORE), showed that one-third of them, experience high-risk 
atherosclerosis when age older than 49.5 years and/or cholesterol 
levels over 5.4 mmol/l suggest that they should be managed 
appropriately [32]. Similar conclusions of increased subclinical 
atherosclerosis were made in another prospective study in 71 RA 
patients ≤ 60 years old compared to 40 age- and sex-matched 
controls [33].
In conclusion, our results corroborate other studies that show in-
creased incidence of cardiovascular risk in RA female patients com-
pared to control individuals. The presence of increased risk even in 
patients with minimal or atypical cardiac symptoms indicates that 
early detection of the increased risk in RA patients is warranted in 
order to monitor or pharmaceutically reverse the indolent cardio-
vascular disease.
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